{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:49:05Z","timestamp":1791355745651,"version":"4.3.1"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1996,11]]},"abstract":"<jats:p>The feasibility of using the highly purified native attachment (G) protein in a subunit vaccine against respiratory syncytial virus (RSV) was examined in a murine model with or without the fusion (F) protein of RSV and the adjuvant QS-21. The studies established that QS-21 was more potent than AIOH as an adjuvant for both F and G glycoproteins. Augmented antigen-dependent killer cell activity and complement-assisted serum neutralizing and anti-F and G protein immunoglobulin G2a antibody titers were observed. Immunization with G\/QS-21 generated immune responses that were characterized by low levels of antigen-dependent killer cell activity, elevated levels of interleukin-5 (IL-5) and percentages of eosinophils in the bronchoalveolar lavage fluids after challenge, and splenic immunocytes that secreted IL-5 but not gamma interferon (IFN-gamma) after in vitro stimulation with purified whole virus antigens. The pulmonary eosinophilia was similar to that induced by a facsimile of a formalin-inactivated vaccine used in previous clinical trials and was prevented by prior in vivo treatment with anti-IL-5 but not with control immunoglobulin G or anti-IFN-gamma neutralizing monoclonal antibodies. Thus the data implied that vaccination with G\/QS-21 generated helper T-cell immune responses that were type 2 in nature. Alternatively, the data suggested that the helper T-cell immune responses elicited by F\/QS-21 were more type 1 in character. Neither eosinophilia nor elevated levels of IL-5 were observed in the lungs of mice after challenge. Noteworthy levels of antigen-dependent killer cell activity was observed, and splenic immunocytes secreted copious quantities of IFN-gamma. Immunization with a combination vaccine composed of highly purified native F and G proteins plus QS-21 (F+G\/QS-21) resulted in augmented complement-assisted serum neutralizing antibody titers compared with vaccination with either F\/QS-21 or G\/QS-21 alone. However, following vaccination with F+G\/QS-21, the bronchoalveolar lavage fluids contained significant increases in IL-5 and percentages of eosinophils after challenge, the spleen cells appeared to secrete less IFN-gamma after in vitro stimulation, and there was no evidence of increased numbers of antigen-dependent killer cell precursors. Taken together, the data imply that native G protein influences the nature of the immune responses elicited by F\/QS-21. The results therefore suggest that G, not F, protein has more potential to bias the host for atypical pulmonary inflammatory responses.<\/jats:p>","DOI":"10.1128\/jvi.70.11.7783-7791.1996","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T21:41:39Z","timestamp":1578346899000},"page":"7783-7791","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":129,"title":["Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus"],"prefix":"10.1128","volume":"70","author":[{"given":"G E","family":"Hancock","sequence":"first","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Speelman","sequence":"additional","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Heers","sequence":"additional","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bortell","sequence":"additional","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cosco","sequence":"additional","affiliation":[{"name":"Department of Immunology, Lederle-Praxis Biologicals, Inc., West Henrietta, New York 14586-9728, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.70.11.7783-7791.1996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.70.11.7783-7791.1996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:14:31Z","timestamp":1646486071000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.70.11.7783-7791.1996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1128\/jvi.70.11.7783-7791.1996"],"URL":"https:\/\/doi.org\/10.1128\/jvi.70.11.7783-7791.1996","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]},"assertion":[{"value":"1996-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}